Editorial: Clinical phytopharmacology

Merlin L Willcox; Chi-Jung Tai; Kaushik Chattopadhyay; Xiao-Yang Hu; Michael Heinrich

doi:10.3389/fphar.2023.1353483

Editorial: Clinical phytopharmacology

Front Pharmacol. 2024 Jan 15:14:1353483. doi: 10.3389/fphar.2023.1353483. eCollection 2023.

Authors

Merlin L Willcox¹, Chi-Jung Tai², Kaushik Chattopadhyay^{3

4}, Xiao-Yang Hu¹, Michael Heinrich^{5

6}

Affiliations

¹ Primary Care Research Centre, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
² Department of Family Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
³ Lifespan and Population Health, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
⁴ The Nottingham Centre for Evidence-Based Healthcare: A JBI Centre of Excellence, Nottingham, United Kingdom.
⁵ Pharmacognosy and Phytotherapy Group, UCL School of Pharmacy, London, United Kingdom.
⁶ Chinese Medicine Research Center, College of Chinese Medicine, China Medical University, Taichung, Taiwan.

No abstract available

Keywords: CONSORT; ConPhyMP; clinical studies; phytopharmacology; quality assurance; traditional medicine.

Publication types

Editorial

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. MW’s salary is partly funded by the National Institute for Health Research (NIHR 302412). X-YH’s salary is partly funded by the NIHR School for Primary Care Research (NIHR SPCR 669). The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care.